News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare Disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Intralymphatic Histiocytosis Treated With Intralesional Triamcinolone Acetonide and Pressure Bandage
MDedge Dermatology
Low incidence of HS in children does not diminish importance of early diagnosis
MDedge Dermatology
Perianal Basal Cell Carcinoma Treated With Mohs Micrographic Surgery
MDedge Dermatology
Secukinumab Emerges as a Rapidly Effective Therapy for Pityriasis Rubra Pilaris
MDedge Dermatology
Discoid Lupus Erythematosus Following Herpes Zoster
MDedge Dermatology
Squamoid Eccrine Ductal Carcinoma
MDedge Dermatology
Collagen remodeling observed after laser treatment in EB patient
MDedge Dermatology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Dermatology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Dermatology
RFPs Available for the Study of Three Rare Diseases
MDedge Dermatology